MOLECULAR CANCER RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891471, encodeId=fba08914e1b9, content=这个刊不火呀。有没有投综述的老大哥？一般一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Mon Oct 12 15:22:43 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583581, encodeId=493958358112, content=2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584428, encodeId=c90d5844282b, content=***178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, beContent=178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32575317, createdName=12590c78m06暂无昵称, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583738, encodeId=9c5e583e3891, content=文章今天已经顺利接收了189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠189PlKQ1410(暂无昵称) 2020-01-18 00:00:00 发表: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582561, encodeId=03ee582561da, content=已发送189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***189PlKQ1410(暂无昵称) 2020-01-02 00:00:00 发表: ***, beContent=189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581366, encodeId=175e58136684, content=您好，有参考文件格式吗？能否发给我一份，379050421@qq.com, 谢谢！189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=r4UFRWMJMmT6yURUwicNPibQ&s=100&t=1556929510, createdBy=36985245425, createdName=一口老谭, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581236, encodeId=bd125812363b, content=您好，请问您还有参考文献格式吗，可否方便发一份，谢谢了。我的邮箱是771128365@qq.com189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60882530625, createdName=771128365_61423734, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580454, encodeId=c7bb5804540b, content=你好能否给我发一份的，我的邮箱1780787724@qq.com189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/28/9ed65ccb22d50f4b9d4109d063e712a6.jpg, createdBy=c7ed2477700, createdName=王显文, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=)]

2019-11-01 14633d32m83(暂无昵称)

请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表:
我有，您还需要吗？

189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？

115 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891471, encodeId=fba08914e1b9, content=这个刊不火呀。有没有投综述的老大哥？一般一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Mon Oct 12 15:22:43 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583581, encodeId=493958358112, content=2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584428, encodeId=c90d5844282b, content=***178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, beContent=178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32575317, createdName=12590c78m06暂无昵称, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583738, encodeId=9c5e583e3891, content=文章今天已经顺利接收了189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠189PlKQ1410(暂无昵称) 2020-01-18 00:00:00 发表: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582561, encodeId=03ee582561da, content=已发送189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***189PlKQ1410(暂无昵称) 2020-01-02 00:00:00 发表: ***, beContent=189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581366, encodeId=175e58136684, content=您好，有参考文件格式吗？能否发给我一份，379050421@qq.com, 谢谢！189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=r4UFRWMJMmT6yURUwicNPibQ&s=100&t=1556929510, createdBy=36985245425, createdName=一口老谭, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581236, encodeId=bd125812363b, content=您好，请问您还有参考文献格式吗，可否方便发一份，谢谢了。我的邮箱是771128365@qq.com189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60882530625, createdName=771128365_61423734, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580454, encodeId=c7bb5804540b, content=你好能否给我发一份的，我的邮箱1780787724@qq.com189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/28/9ed65ccb22d50f4b9d4109d063e712a6.jpg, createdBy=c7ed2477700, createdName=王显文, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=)]

2020-02-05 小悍马

可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表:
文章今天已经顺利接收了

tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了

149 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891471, encodeId=fba08914e1b9, content=这个刊不火呀。有没有投综述的老大哥？一般一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Mon Oct 12 15:22:43 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583581, encodeId=493958358112, content=2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584428, encodeId=c90d5844282b, content=***178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, beContent=178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32575317, createdName=12590c78m06暂无昵称, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583738, encodeId=9c5e583e3891, content=文章今天已经顺利接收了189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠189PlKQ1410(暂无昵称) 2020-01-18 00:00:00 发表: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582561, encodeId=03ee582561da, content=已发送189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***189PlKQ1410(暂无昵称) 2020-01-02 00:00:00 发表: ***, beContent=189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581366, encodeId=175e58136684, content=您好，有参考文件格式吗？能否发给我一份，379050421@qq.com, 谢谢！189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=r4UFRWMJMmT6yURUwicNPibQ&s=100&t=1556929510, createdBy=36985245425, createdName=一口老谭, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581236, encodeId=bd125812363b, content=您好，请问您还有参考文献格式吗，可否方便发一份，谢谢了。我的邮箱是771128365@qq.com189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60882530625, createdName=771128365_61423734, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580454, encodeId=c7bb5804540b, content=你好能否给我发一份的，我的邮箱1780787724@qq.com189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/28/9ed65ccb22d50f4b9d4109d063e712a6.jpg, createdBy=c7ed2477700, createdName=王显文, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=)]

2020-10-12 Nevermorx

这个刊不火呀。有没有投综述的老大哥？一般一审多久？

98 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891471, encodeId=fba08914e1b9, content=这个刊不火呀。有没有投综述的老大哥？一般一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Mon Oct 12 15:22:43 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583581, encodeId=493958358112, content=2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584428, encodeId=c90d5844282b, content=***178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, beContent=178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32575317, createdName=12590c78m06暂无昵称, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583738, encodeId=9c5e583e3891, content=文章今天已经顺利接收了189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠189PlKQ1410(暂无昵称) 2020-01-18 00:00:00 发表: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582561, encodeId=03ee582561da, content=已发送189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***189PlKQ1410(暂无昵称) 2020-01-02 00:00:00 发表: ***, beContent=189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581366, encodeId=175e58136684, content=您好，有参考文件格式吗？能否发给我一份，379050421@qq.com, 谢谢！189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=r4UFRWMJMmT6yURUwicNPibQ&s=100&t=1556929510, createdBy=36985245425, createdName=一口老谭, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581236, encodeId=bd125812363b, content=您好，请问您还有参考文献格式吗，可否方便发一份，谢谢了。我的邮箱是771128365@qq.com189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60882530625, createdName=771128365_61423734, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580454, encodeId=c7bb5804540b, content=你好能否给我发一份的，我的邮箱1780787724@qq.com189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/28/9ed65ccb22d50f4b9d4109d063e712a6.jpg, createdBy=c7ed2477700, createdName=王显文, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=)]

2020-01-18 120cc505m10(暂无昵称)

2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠

33 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891471, encodeId=fba08914e1b9, content=这个刊不火呀。有没有投综述的老大哥？一般一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Mon Oct 12 15:22:43 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583581, encodeId=493958358112, content=2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584428, encodeId=c90d5844282b, content=***178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, beContent=178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32575317, createdName=12590c78m06暂无昵称, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583738, encodeId=9c5e583e3891, content=文章今天已经顺利接收了189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠189PlKQ1410(暂无昵称) 2020-01-18 00:00:00 发表: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582561, encodeId=03ee582561da, content=已发送189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***189PlKQ1410(暂无昵称) 2020-01-02 00:00:00 发表: ***, beContent=189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581366, encodeId=175e58136684, content=您好，有参考文件格式吗？能否发给我一份，379050421@qq.com, 谢谢！189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=r4UFRWMJMmT6yURUwicNPibQ&s=100&t=1556929510, createdBy=36985245425, createdName=一口老谭, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581236, encodeId=bd125812363b, content=您好，请问您还有参考文献格式吗，可否方便发一份，谢谢了。我的邮箱是771128365@qq.com189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60882530625, createdName=771128365_61423734, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580454, encodeId=c7bb5804540b, content=你好能否给我发一份的，我的邮箱1780787724@qq.com189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/28/9ed65ccb22d50f4b9d4109d063e712a6.jpg, createdBy=c7ed2477700, createdName=王显文, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=)]

2020-02-08 12590c78m06暂无昵称

***178****9006暂无昵称 2020-02-08 00:00:00 发表:
亲可以给我一份格式嘛

178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛

102 0

[GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891471, encodeId=fba08914e1b9, content=这个刊不火呀。有没有投综述的老大哥？一般一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Mon Oct 12 15:22:43 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583581, encodeId=493958358112, content=2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584428, encodeId=c90d5844282b, content=***178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, beContent=178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32575317, createdName=12590c78m06暂无昵称, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583738, encodeId=9c5e583e3891, content=文章今天已经顺利接收了189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠189PlKQ1410(暂无昵称) 2020-01-18 00:00:00 发表: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582561, encodeId=03ee582561da, content=已发送189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***189PlKQ1410(暂无昵称) 2020-01-02 00:00:00 发表: ***, beContent=189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581366, encodeId=175e58136684, content=您好，有参考文件格式吗？能否发给我一份，379050421@qq.com, 谢谢！189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=r4UFRWMJMmT6yURUwicNPibQ&s=100&t=1556929510, createdBy=36985245425, createdName=一口老谭, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581236, encodeId=bd125812363b, content=您好，请问您还有参考文献格式吗，可否方便发一份，谢谢了。我的邮箱是771128365@qq.com189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60882530625, createdName=771128365_61423734, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580454, encodeId=c7bb5804540b, content=你好能否给我发一份的，我的邮箱1780787724@qq.com189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/28/9ed65ccb22d50f4b9d4109d063e712a6.jpg, createdBy=c7ed2477700, createdName=王显文, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=)]

2020-01-22 tomsyu

文章今天已经顺利接收了189PlKQ1410(暂无昵称) 2020-01-18 发表::
2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠189PlKQ1410(暂无昵称) 2020-01-18 00:00:00 发表:
2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠

189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠

101 0

[GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891471, encodeId=fba08914e1b9, content=这个刊不火呀。有没有投综述的老大哥？一般一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Mon Oct 12 15:22:43 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583581, encodeId=493958358112, content=2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584428, encodeId=c90d5844282b, content=***178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, beContent=178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32575317, createdName=12590c78m06暂无昵称, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583738, encodeId=9c5e583e3891, content=文章今天已经顺利接收了189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠189PlKQ1410(暂无昵称) 2020-01-18 00:00:00 发表: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582561, encodeId=03ee582561da, content=已发送189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***189PlKQ1410(暂无昵称) 2020-01-02 00:00:00 发表: ***, beContent=189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581366, encodeId=175e58136684, content=您好，有参考文件格式吗？能否发给我一份，379050421@qq.com, 谢谢！189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=r4UFRWMJMmT6yURUwicNPibQ&s=100&t=1556929510, createdBy=36985245425, createdName=一口老谭, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581236, encodeId=bd125812363b, content=您好，请问您还有参考文献格式吗，可否方便发一份，谢谢了。我的邮箱是771128365@qq.com189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60882530625, createdName=771128365_61423734, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580454, encodeId=c7bb5804540b, content=你好能否给我发一份的，我的邮箱1780787724@qq.com189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/28/9ed65ccb22d50f4b9d4109d063e712a6.jpg, createdBy=c7ed2477700, createdName=王显文, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=)]

2020-01-02 120cc505m10(暂无昵称)

已发送189PlKQ1410(暂无昵称) 2020-01-02 发表::
***189PlKQ1410(暂无昵称) 2020-01-02 00:00:00 发表:
***

189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***

118 0

[GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891471, encodeId=fba08914e1b9, content=这个刊不火呀。有没有投综述的老大哥？一般一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Mon Oct 12 15:22:43 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583581, encodeId=493958358112, content=2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584428, encodeId=c90d5844282b, content=***178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, beContent=178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32575317, createdName=12590c78m06暂无昵称, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583738, encodeId=9c5e583e3891, content=文章今天已经顺利接收了189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠189PlKQ1410(暂无昵称) 2020-01-18 00:00:00 发表: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582561, encodeId=03ee582561da, content=已发送189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***189PlKQ1410(暂无昵称) 2020-01-02 00:00:00 发表: ***, beContent=189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581366, encodeId=175e58136684, content=您好，有参考文件格式吗？能否发给我一份，379050421@qq.com, 谢谢！189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=r4UFRWMJMmT6yURUwicNPibQ&s=100&t=1556929510, createdBy=36985245425, createdName=一口老谭, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581236, encodeId=bd125812363b, content=您好，请问您还有参考文献格式吗，可否方便发一份，谢谢了。我的邮箱是771128365@qq.com189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60882530625, createdName=771128365_61423734, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580454, encodeId=c7bb5804540b, content=你好能否给我发一份的，我的邮箱1780787724@qq.com189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/28/9ed65ccb22d50f4b9d4109d063e712a6.jpg, createdBy=c7ed2477700, createdName=王显文, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=)]

2019-12-12 一口老谭

您好，有参考文件格式吗？能否发给我一份，379050421@qq.com, 谢谢！189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表:
邮箱？

189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？

101 0

[GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891471, encodeId=fba08914e1b9, content=这个刊不火呀。有没有投综述的老大哥？一般一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Mon Oct 12 15:22:43 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583581, encodeId=493958358112, content=2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584428, encodeId=c90d5844282b, content=***178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, beContent=178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32575317, createdName=12590c78m06暂无昵称, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583738, encodeId=9c5e583e3891, content=文章今天已经顺利接收了189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠189PlKQ1410(暂无昵称) 2020-01-18 00:00:00 发表: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582561, encodeId=03ee582561da, content=已发送189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***189PlKQ1410(暂无昵称) 2020-01-02 00:00:00 发表: ***, beContent=189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581366, encodeId=175e58136684, content=您好，有参考文件格式吗？能否发给我一份，379050421@qq.com, 谢谢！189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=r4UFRWMJMmT6yURUwicNPibQ&s=100&t=1556929510, createdBy=36985245425, createdName=一口老谭, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581236, encodeId=bd125812363b, content=您好，请问您还有参考文献格式吗，可否方便发一份，谢谢了。我的邮箱是771128365@qq.com189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60882530625, createdName=771128365_61423734, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580454, encodeId=c7bb5804540b, content=你好能否给我发一份的，我的邮箱1780787724@qq.com189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/28/9ed65ccb22d50f4b9d4109d063e712a6.jpg, createdBy=c7ed2477700, createdName=王显文, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=)]

2019-12-10 771128365_61423734

您好，请问您还有参考文献格式吗，可否方便发一份，谢谢了。我的邮箱是771128365@qq.com189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表:
邮箱？

189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？

116 0

[GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891471, encodeId=fba08914e1b9, content=这个刊不火呀。有没有投综述的老大哥？一般一审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Mon Oct 12 15:22:43 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583581, encodeId=493958358112, content=2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584428, encodeId=c90d5844282b, content=***178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, beContent=178****9006暂无昵称 2020-02-08 00:00:00 发表: 亲可以给我一份格式嘛, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32575317, createdName=12590c78m06暂无昵称, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583738, encodeId=9c5e583e3891, content=文章今天已经顺利接收了189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠189PlKQ1410(暂无昵称) 2020-01-18 00:00:00 发表: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, beContent=189PlKQ1410(暂无昵称) 2020-01-18 发表:: 2019年8月投的，9月底一审回，给了2个月的时间大修，12月初修回，二审一个半月，审稿人有一种死磕到底的决心，抓着几个问题，狂追猛打，不大友好。2个月的时间让我们做原位成瘤?转基因小鼠, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582561, encodeId=03ee582561da, content=已发送189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***189PlKQ1410(暂无昵称) 2020-01-02 00:00:00 发表: ***, beContent=189PlKQ1410(暂无昵称) 2020-01-02 发表:: ***, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581366, encodeId=175e58136684, content=您好，有参考文件格式吗？能否发给我一份，379050421@qq.com, 谢谢！189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=r4UFRWMJMmT6yURUwicNPibQ&s=100&t=1556929510, createdBy=36985245425, createdName=一口老谭, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581236, encodeId=bd125812363b, content=您好，请问您还有参考文献格式吗，可否方便发一份，谢谢了。我的邮箱是771128365@qq.com189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60882530625, createdName=771128365_61423734, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580454, encodeId=c7bb5804540b, content=你好能否给我发一份的，我的邮箱1780787724@qq.com189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/28/9ed65ccb22d50f4b9d4109d063e712a6.jpg, createdBy=c7ed2477700, createdName=王显文, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=)]

2019-11-26 王显文

你好能否给我发一份的，我的邮箱1780787724@qq.com189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表:
我有，您还需要吗？

189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？

117 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务